The Ethics of Gene Editing

In recent years, scientists have developed tools that allow them to change the genetic instructions inside living cells with remarkable precision. The best known of these tools, often referred to simply by the name CRISPR, works rather like a pair of molecular scissors, cutting the long chain of DNA at a chosen point so that a faulty gene can be repaired, removed, or replaced. What makes the technology so important is not only its accuracy but its convenience: it is far cheaper, faster, and easier to use than the methods that came before it. As a result, it has spread rapidly through laboratories all over the world. With it comes the genuine hope of curing diseases that have troubled and shortened human lives for centuries.

Much of this hope rests on what scientists call somatic gene editing, which changes the cells of a single patient without affecting future generations. Doctors have already used such techniques to treat certain serious blood disorders, correcting the faulty cells responsible for a patient's suffering and, in some cases, apparently curing them. Because these changes are made only in one person's body and cannot be passed on to that person's children, most researchers regard this kind of treatment as ethically similar to other advanced medical procedures. The main questions it raises concern safety, long-term effects, cost, and the difficult matter of who will be able to afford it.

Far more controversial is the editing of human embryos, eggs, or sperm, a practice known as germline editing. Any change made at this early stage would appear in every cell of the resulting person and would be inherited by all of their descendants, generation after generation. Supporters argue that this could permanently remove devastating inherited diseases from a family forever. Critics warn, however, that our knowledge of how genes interact remains dangerously incomplete, and that a single unexpected error could be passed down endlessly. They also fear that the same techniques might eventually be used not to cure illness at all, but to select desirable traits such as height or appearance, creating children effectively designed to order.

The debate became urgent in 2018, when a scientist announced that he had helped create the world's first gene-edited babies. Rather than the praise he may have expected, the news was met with widespread shock and condemnation from researchers around the world, and the scientist was later imprisoned. Most countries now ban germline editing in humans, while continuing to support carefully regulated research on somatic treatments. The episode highlighted a difficulty that will not soon disappear: scientific ability often advances faster than society's agreement about how that ability should be used. Deciding exactly where to draw the line, many people argue, is a question far too important to be left to scientists alone.